Articaine versus lidocaine plus bupivacaine for peribulbar anaesthesia in cataract surgery

Background. We compared the efficacy and safety of articaine2% with a mixture of lidocaine 2% and bupivacaine 0.5% withouthyaluronidase for peribulbar anaesthesia in cataract surgery. Method. In this double-blind randomized clinical study, 58 cataractpatients were allocated to receive either articaine 2% withepinephrine 1:200 000 or a mixture of equal parts of lidocaine2% with epinephrine 1.25:100 000 and bupivacaine 0.5%. Ocularand eyelid movement scores, the number of supplementary injections,total volume of solution used and pain and complications duringinjection and surgery were used as clinical end-points. Results. Articaine produced greater akinesia after 5 min (P=0.03).Eighteen patients (60%) in the articaine group and 26 (93%)in the lidocaine/bupivacaine group required a second injection(P=0.003). A third injection was needed by two patients (7%)in the articaine group and 12 (43%) in the lidocaine/bupivacainegroup (P=0.001). The total mean volume of local anaestheticrequired to achieve akinesia was mean 9.4 (SD 1.7) ml in thearticaine group and 11.28 (1.86) ml in the lidocaine/bupivacainegroup (P<0.001). Median pain score was lower in the articainegroup than in lidocaine/bupivacaine group during injection (P=0.004)and surgery (P=0.014). There was no difference between the groupsfor the incidence of complications. Conclusion. Articaine 2% without hyaluronidase is more advantageousthan a mixture of lidocaine 2% and bupivacaine 0.5% withouthyaluronidase for peribulbar anaesthesia in cataract surgery. Br J Anaesth 2004; 92: 231–4